Name: Cell Based Assays Market by Offering (Consumables (Reagents, Assay Kits, Cell Lines, Microplates, Probes, Labels), Instruments & Software), Technology (Flow Cytometry, HTS), Application (Drug Discovery (Toxicity, PK/PD Studies)) - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: BT2486
Price: 4950 USD
Availability: InStock

1 INTRODUCTION 38 1.1 STUDY OBJECTIVES 38 1.2 MARKET DEFINITION 38 1.3 STUDY SCOPE 39 1.3.1 INCLUSIONS & EXCLUSIONS 39 1.3.2 MARKET SEGMENTATION AND REGIONAL SCOPE 40 1.3.3 YEARS CONSIDERED 41 1.3.4 CURRENCY CONSIDERED 41 1.4 STAKEHOLDERS 41 1.5 SUMMARY OF CHANGES 42 2 RESEARCH METHODOLOGY 43 2.1 RESEARCH DATA 43 2.1.1 SECONDARY DATA 44 2.1.2 PRIMARY DATA 45 2.2 MARKET SIZE ESTIMATION 46 2.2.1 GLOBAL MARKET ESTIMATION (BOTTOM-UP APPROACH) 46 2.2.2 INSIGHTS FROM PRIMARY EXPERTS 48 2.2.3 SEGMENTAL MARKET ESTIMATION (TOP-DOWN APPROACH) 49 2.3 MARKET GROWTH RATE PROJECTIONS 50 2.4 DATA TRIANGULATION 52 2.5 RESEARCH ASSUMPTIONS 52 2.6 RISK ANALYSIS 53 2.7 RESEARCH LIMITATIONS 54 3 EXECUTIVE SUMMARY 55 4 PREMIUM INSIGHTS 59 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN CELL-BASED ASSAYS MARKET 59 4.2 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER AND COUNTRY (2024) 60 4.3 CELL-BASED ASSAYS MARKET, BY OFFERING, 2024 60 4.4 CELL-BASED ASSAYS MARKET, BY END USER, 2024 61 4.5 CELL-BASED ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61 5 MARKET OVERVIEW 62 5.1 INTRODUCTION 62 5.2 MARKET DYNAMICS 62 5.2.1 DRIVERS 64 5.2.1.1 Growing demand for drug discovery & development and increasing preference for cell-based assays in drug discovery 64 5.2.1.2 Government support and funding for cell-based research 65 5.2.1.3 Growing efforts to curtail animal-based studies 66 5.2.1.4 Rising prevalence of cancer 66 5.2.1.5 Alliances to accelerate innovations in drug discovery 68 5.2.2 RESTRAINTS 69 5.2.2.1 High cost of instruments and restrictions imposed by product end-user licenses for reagents 69 5.2.2.2 Lack of standardization of protocols used in cell-based assays 69 5.2.3 OPPORTUNITIES 70 5.2.3.1 Growing applications of cell-based assays in chronic diseases and personalized medicine 70 5.2.3.2 Growth opportunities in emerging economies 71 5.2.3.3 Rising adoption of AI in drug discovery and cell analysis 72 5.2.4 CHALLENGES 73 5.2.4.1 Complexities in assay designs 73 5.2.4.2 Shortage of skilled professionals 73 5.3 TECHNOLOGY ANALYSIS 73 5.3.1 KEY TECHNOLOGIES 73 5.3.1.1 Flow cytometry 73 5.3.1.2 High-throughput screening 74 5.3.1.3 High-content screening 74 5.3.1.4 Label-free detection 75 5.3.2 COMPLEMENTARY TECHNOLOGIES 75 5.3.2.1 Artificial intelligence and machine learning 75 5.3.3 ADJACENT TECHNOLOGIES 76 5.3.3.1 Nanotechnology 76 5.4 VALUE CHAIN ANALYSIS 76 5.5 PRICING ANALYSIS 78 5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021–2024 79 5.5.2 AVERAGE SELLING PRICE OF CELL-BASED ASSAYS, BY REGION, 2024 80 5.6 ECOSYSTEM ANALYSIS 80 5.6.1 RAW MATERIAL VENDORS 81 5.6.2 PRODUCT/SERVICE VENDORS 81 5.6.3 END USERS 82 5.6.4 REGULATORY BODIES 82 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 83 5.8 PATENT ANALYSIS 83 5.8.1 NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2014–2025 84 5.9 KEY CONFERENCES & EVENTS, 2025–2026 86 5.10 TARIFF AND REGULATORY LANDSCAPE 86 5.10.1 TARIFF RELATED TO CELL-BASED ASSAY PRODUCTS 86 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 5.10.3 REGULATORY FRAMEWORK 90 5.10.3.1 North America 90 5.10.3.2 Europe 90 5.10.3.3 Asia Pacific 90 5.10.3.4 Rest of the World 91 5.11 PORTER’S FIVE FORCES ANALYSIS 92 5.11.1 THREAT OF NEW ENTRANTS 93 5.11.2 THREAT OF SUBSTITUTES 93 5.11.3 BARGAINING POWER OF SUPPLIERS 93 5.11.4 BARGAINING POWER OF BUYERS 93 5.11.5 INTENSITY OF COMPETITIVE RIVALRY 93 5.12 KEY STAKEHOLDERS & BUYING CRITERIA 94 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 94 5.12.2 BUYING CRITERIA 95 5.13 INVESTMENT AND FUNDING SCENARIO 96 5.14 TRADE ANALYSIS 97 5.14.1 IMPORT DATA 97 5.14.2 EXPORT DATA 99 5.15 IMPACT OF AI/GENERATIVE AI ON CELL-BASED ASSAYS MARKET 100 5.16 IMPACT OF 2025 US TARIFF ON CELL-BASED ASSAYS MARKET 102 5.16.1 INTRODUCTION 102 5.16.2 KEY TARIFF RATES 102 5.16.3 PRICE IMPACT ANALYSIS 103 5.16.4 IMPACT ON COUNTRY/REGION 104 5.16.4.1 US 104 5.16.4.2 Europe 104 5.16.4.3 Asia Pacific 104 5.16.5 IMPACT ON END-USE INDUSTRIES 105 5.16.5.1 Pharmaceutical & biotech companies 105 5.16.5.2 Contract research organizations (CROs) 106 5.16.5.3 Academic & research institutes 106 6 CELL-BASED ASSAYS MARKET, BY OFFERING 107 6.1 INTRODUCTION 108 6.2 CONSUMABLES 108 6.2.1 REAGENTS 113 6.2.1.1 High demand for reagents in research applications to propel market growth 113 6.2.2 ASSAY KITS 116 6.2.2.1 Reporter gene assays 120 6.2.2.1.1 Versatility of reporter gene assays and widespread applications to fuel growth 120 6.2.2.2 Cell growth assays 124 6.2.2.2.1 Rising use of cell viability and cell proliferation assays for assessing cell growth to boost market 124 6.2.2.3 Secondary messenger assays 128 6.2.2.3.1 Adoption of secondary messenger assays for cell signaling studies to fuel growth 128 6.2.2.4 Cell death assays 132 6.2.2.4.1 Importance of cell death quantification in drug development to favor growth 132 6.2.2.5 Other assay kits 135 6.2.3 MICROPLATES 138 6.2.3.1 Demand for microplates in assay development to drive market 138 6.2.4 CELL LINES 141 6.2.4.1 Immortalized cell lines 144 6.2.4.1.1 Wide use of immortalized cell lines to boost market 144 6.2.4.2 Primary cell lines 147 6.2.4.2.1 Advantages in drug development, preclinical research, and other applications to propel market 147 6.2.4.3 Stem cell lines 151 6.2.4.3.1 Rising use in tissue and disease models to fuel adoption 151 6.2.5 PROBES & LABELS 154 6.2.5.1 Growing need for effective cell labeling to boost demand 154 6.2.6 OTHER CONSUMABLES 158 6.3 INSTRUMENTS 161 6.3.1 AUTOMATION IN INSTRUMENTS TO DRIVE SEGMENTAL GROWTH 161 6.4 SERVICES 165 6.4.1 GROWING NUMBER OF CROS PROVIDING DRUG DISCOVERY AND SCREENING SERVICES TO ACCELERATE GROWTH 165 6.5 SOFTWARE 168 6.5.1 INCREASING ADOPTION OF SOFTWARE FOR EFFICIENT DATA ANALYSIS TO DRIVE GROWTH 168 7 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY 171 7.1 INTRODUCTION 172 7.2 FLOW CYTOMETRY 172 7.2.1 WIDE USAGE OF FLOW CYTOMETRY IN CELL-BASED ASSAYS TO DRIVE MARKET 172 7.3 HIGH-THROUGHPUT SCREENING 176 7.3.1 INCREASING INVESTMENTS AND FUNDING FOR LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH 176 7.4 LABEL-FREE DETECTION 179 7.4.1 GROWING ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE DEMAND 179 7.5 OTHER TECHNOLOGIES 183 8 CELL-BASED ASSAYS MARKET, BY APPLICATION 186 8.1 INTRODUCTION 187 8.2 DRUG DISCOVERY 187 8.2.1 TOXICITY STUDIES 191 8.2.1.1 Increasing demand for cell-based assays in toxicity testing to fuel growth 191 8.2.2 PHARMACOKINETIC STUDIES 195 8.2.2.1 Growing focus on ADME studies in pharmacokinetics to propel demand for cell-based assays 195 8.2.3 PHARMACODYNAMIC STUDIES 199 8.2.3.1 Advantages of cell-based assays in pharmacodynamics to propel growth 199 8.3 BASIC RESEARCH 203 8.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES 203 8.4 GENETIC STUDIES 207 8.4.1 INCREASING FUNDING FOR GENETIC RESEARCH TO DRIVE MARKET 207 8.5 OTHER APPLICATIONS 210 9 CELL-BASED ASSAYS MARKET, BY END USER 214 9.1 INTRODUCTION 215 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 215 9.2.1 GROWTH IN R&D EFFORTS TOWARD CELL-BASED ASSAYS IN PHARMACEUTICAL AND BIOPHARMACEUTICAL SECTORS TO DRIVE MARKET 215 9.3 CONTRACT RESEARCH ORGANIZATIONS 220 9.3.1 GROWING PREFERENCE FOR OUTSOURCING TO DRIVE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH 220 9.4 ACADEMIC & RESEARCH INSTITUTES 224 9.4.1 RISING FOCUS ON DEVELOPING ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE MARKET 224 10 CELL-BASED ASSAYS MARKET, BY REGION 228 10.1 INTRODUCTION 229 10.2 NORTH AMERICA 229 10.2.1 MACROECONOMIC OUTLOOK 230 10.2.2 US 235 10.2.2.1 Established pharmaceutical and biotechnology sectors to drive market 235 10.2.3 CANADA 239 10.2.3.1 Increasing funding and investments to drive market 239 10.3 EUROPE 242 10.3.1 MACROECONOMIC OUTLOOK 242 10.3.2 GERMANY 246 10.3.2.1 To dominate cell-based assays market in Europe 246 10.3.3 UK 250 10.3.3.1 Growing cancer research funding to increase demand for cell-based assays 250 10.3.4 FRANCE 254 10.3.4.1 Growing biotechnology sector to drive market 254 10.3.5 ITALY 258 10.3.5.1 Growth of pharmaceutical industry to boost market 258 10.3.6 SPAIN 261 10.3.6.1 Rising research activity and increasing number of biotech companies to favor market growth 261 10.3.7 REST OF EUROPE 264 10.4 ASIA PACIFIC 267 10.4.1 MACROECONOMIC OUTLOOK 268 10.4.2 CHINA 273 10.4.2.1 Increasing R&D expenditure to favor market growth 273 10.4.3 JAPAN 277 10.4.3.1 Government initiatives for drug innovation to support market growth 277 10.4.4 INDIA 280 10.4.4.1 Increasing investments in R&D and funding for life science research to propel market 280 10.4.5 AUSTRALIA 284 10.4.5.1 Booming life science sector to propel market 284 10.4.6 SOUTH KOREA 287 10.4.6.1 Increasing strategic alliances to support market growth 287 10.4.7 REST OF ASIA PACIFIC 290 10.5 LATIN AMERICA 294 10.5.1 MACROECONOMIC OUTLOOK 294 10.5.2 BRAZIL 298 10.5.2.1 Brazil to hold largest share of Latin American market 298 10.5.3 MEXICO 302 10.5.3.1 Government support for biopharmaceutical production to support market growth 302 10.5.4 REST OF LATIN AMERICA 305 10.6 MIDDLE EAST 308 10.6.1 MACROECONOMIC OUTLOOK 308 10.6.2 GCC COUNTRIES 312 10.6.2.1 Saudi Arabia 315 10.6.2.1.1 Increasing R&D investments to drive market 315 10.6.2.2 UAE 319 10.6.2.2.1 Investments and support for biopharma sector to offer growth opportunities 319 10.6.2.3 Rest of GCC Countries 322 10.6.3 REST OF MIDDLE EAST 325 10.7 AFRICA 329 10.7.1 RISING NEED FOR EFFECTIVE DIAGNOSTICS TO SUPPORT MARKET GROWTH 329 10.7.2 MACROECONOMIC OUTLOOK 329 11 COMPETITIVE LANDSCAPE 333 11.1 OVERVIEW 333 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025 333 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CELL-BASED ASSAYS MARKET 334 11.3 REVENUE ANALYSIS, 2020–2024 336 11.4 MARKET SHARE ANALYSIS, 2024 337 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 339 11.5.1 STARS 339 11.5.2 EMERGING LEADERS 340 11.5.3 PERVASIVE PLAYERS 340 11.5.4 PARTICIPANTS 340 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 342 11.5.5.1 Company footprint 342 11.5.5.2 Offering footprint 343 11.5.5.3 Technology footprint 344 11.5.5.4 Application Footprint 345 11.5.5.5 Region footprint 346 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 347 11.6.1 PROGRESSIVE COMPANIES 347 11.6.2 RESPONSIVE COMPANIES 347 11.6.3 DYNAMIC COMPANIES 347 11.6.4 STARTING BLOCKS 347 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 349 11.6.5.1 Detailed list of key startups/SMEs 349 11.6.5.2 Competitive benchmarking of key emerging players/startups 351 11.7 COMPANY VALUATION & FINANCIAL METRICS 352 11.8 BRAND/PRODUCT COMPARISON 353 11.9 COMPETITIVE SCENARIO 354 11.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 354 11.9.2 DEALS 355 11.9.3 EXPANSIONS 356 12 COMPANY PROFILES 357 12.1 INTRODUCTION 357 12.2 KEY PLAYERS 357 12.2.1 DANAHER 357 12.2.1.1 Business overview 357 12.2.1.2 Products/Services offered 359 12.2.1.3 Recent developments 361 12.2.1.3.1 Deals 361 12.2.1.3.2 Expansions 362 12.2.1.4 MnM view 362 12.2.1.4.1 Key strengths 362 12.2.1.4.2 Strategic choices 362 12.2.1.4.3 Weaknesses & competitive threats 362 12.2.2 THERMO FISHER SCIENTIFIC INC. 363 12.2.2.1 Business overview 363 12.2.2.2 Products/Services offered 364 12.2.2.3 Recent developments 368 12.2.2.3.1 Deals 368 12.2.2.3.2 Expansions 369 12.2.2.3.3 Other developments 369 12.2.2.4 MnM view 369 12.2.2.4.1 Key strengths 369 12.2.2.4.2 Strategic choices 370 12.2.2.4.3 Weaknesses & competitive threats 370 12.2.3 MERCK KGAA 371 12.2.3.1 Business overview 371 12.2.3.2 Products/Services offered 372 12.2.3.3 Recent developments 375 12.2.3.3.1 Deals 375 12.2.3.3.2 Expansions 375 12.2.3.4 MnM view 376 12.2.3.4.1 Key strengths 376 12.2.3.4.2 Strategic choices 376 12.2.3.4.3 Weaknesses & competitive threats 376 12.2.4 BD 377 12.2.4.1 Business overview 377 12.2.4.2 Products/Services offered 378 12.2.4.3 Recent developments 381 12.2.4.3.1 Product launches 381 12.2.4.3.2 Deals 381 12.2.4.4 MnM view 382 12.2.4.4.1 Key strengths 382 12.2.4.4.2 Strategic choices 382 12.2.4.4.3 Weaknesses & competitive threats 382 12.2.5 AGILENT TECHNOLOGIES, INC. 383 12.2.5.1 Business overview 383 12.2.5.2 Products/Services offered 384 12.2.5.3 Recent developments 385 12.2.5.3.1 Product launches 385 12.2.5.4 MnM view 385 12.2.5.4.1 Key strengths 385 12.2.5.4.2 Strategic choices 386 12.2.5.4.3 Weaknesses & competitive threats 386 12.2.6 LONZA 387 12.2.6.1 Business overview 387 12.2.6.2 Products/Services offered 388 12.2.6.3 Recent developments 389 12.2.6.3.1 Deals 389 12.2.6.3.2 Expansions 389 12.2.7 EUROFINS SCIENTIFIC 390 12.2.7.1 Business overview 390 12.2.7.2 Products/Services offered 391 12.2.7.3 Recent developments 393 12.2.7.3.1 Deals 393 12.2.8 CHARLES RIVER LABORATORIES 394 12.2.8.1 Business overview 394 12.2.8.2 Products/services offered 395 12.2.8.3 Recent developments 397 12.2.8.3.1 Service launches 397 12.2.8.3.2 Deals 397 12.2.9 BIO-RAD LABORATORIES, INC. 399 12.2.9.1 Business overview 399 12.2.9.2 Products/Services offered 400 12.2.10 REVVITY 402 12.2.10.1 Business overview 402 12.2.10.2 Products/Services offered 403 12.2.10.3 Recent developments 405 12.2.10.3.1 Product launches 405 12.2.11 SARTORIUS AG 406 12.2.11.1 Business overview 406 12.2.11.2 Products/Services offered 408 12.2.11.3 Recent developments 408 12.2.11.3.1 Expansions 408 12.2.12 CORNING INCORPORATED 409 12.2.12.1 Business overview 409 12.2.12.2 Products/Services offered 410 12.2.13 PROMEGA CORPORATION 412 12.2.13.1 Business overview 412 12.2.13.2 Products/Services offered 412 12.2.13.3 Recent developments 413 12.2.13.3.1 Product launches 413 12.2.14 CELL SIGNALING TECHNOLOGY, INC. 414 12.2.14.1 Business overview 414 12.2.14.2 Products/Services offered 414 12.2.15 ENZO BIOCHEM INC. 416 12.2.15.1 Business overview 416 12.2.15.2 Products/Services offered 417 12.2.15.3 Recent developments 419 12.2.15.3.1 Expansions 419 12.2.16 CARNA BIOSCIENCES, INC. 420 12.2.16.1 Business overview 420 12.2.16.2 Products/Services offered 421 12.2.17 INTERTEK GROUP PLC 423 12.2.17.1 Business overview 423 12.2.17.2 Products/services offered 424 12.2.17.3 Recent developments 425 12.2.17.3.1 Expansions 425 12.2.18 BICO 426 12.2.18.1 Business overview 426 12.2.18.2 Products/Services offered 427 12.3 OTHER PLAYERS 428 12.3.1 CELL BIOLABS, INC. 428 12.3.2 REACTION BIOLOGY 429 12.3.3 AAT BIOQUEST, INC. 430 12.3.4 PESTKA BIOMEDICAL LABORATORIES, INC. 432 12.3.5 NEUROMICS 433 12.3.6 BPS BIOSCIENCE, INC. 433 12.3.7 BELLBROOK LABS 435 12.3.8 PROFACGEN 436 12.3.9 BMG LABTECH GMBH 436 12.3.10 HANUGEN THERAPEUTICS 437 12.3.11 ALTOGEN LABS 438 12.3.12 BIOAGILYTIX LABS 439 13 APPENDIX 440 13.1 DISCUSSION GUIDE 440 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 445 13.3 CUSTOMIZATION OPTIONS 447 13.4 RELATED REPORTS 447 13.5 AUTHOR DETAILS 448

TABLE 1 CELL-BASED ASSAYS MARKET: INCLUSIONS AND EXCLUSIONS 39 TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 51 TABLE 3 CELL-BASED ASSAYS MARKET: IMPACT ANALYSIS 63 TABLE 4 ESTIMATED EXPENDITURE BY US NIH FOR STEM CELL RESEARCH, 2019–2025 65 TABLE 5 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2022 VS. 2045 66 TABLE 6 CELL-BASED ASSAYS MARKET: KEY DEVELOPMENTS 68 TABLE 7 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021–2024 79 TABLE 8 AVERAGE SELLING PRICE OF CELL-BASED ASSAYS, BY REGION, 2024 80 TABLE 9 CELL-BASED ASSAYS MARKET: ROLE OF RAW MATERIAL VENDORS 81 TABLE 10 CELL-BASED ASSAYS MARKET: ROLE OF PRODUCT/SERVICE VENDORS 81 TABLE 11 CELL-BASED ASSAYS MARKET: ROLE OF END USERS 82 TABLE 12 CELL-BASED ASSAYS MARKET: ROLE OF REGULATORY BODIES 82 TABLE 13 NUMBER OF PATENTS APPLIED AND GRANTED, JANUARY 2014–APRIL 2025 84 TABLE 14 INNOVATIONS AND PATENT REGISTRATIONS, 2025 85 TABLE 15 CELL-BASED ASSAYS MARKET: LIST OF KEY CONFERENCES & EVENTS, 2025–2026 86 TABLE 16 AVERAGE TARIFF RELATED TO CELL-BASED ASSAY PRODUCTS FOR HS CODE 9027, 2024 86 TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 20 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 TABLE 21 CELL-BASED ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 92 TABLE 22 BUYING CRITERIA FOR CELL-BASED ASSAY PRODUCTS, BY END USER 95 TABLE 23 IMPORT VALUE FOR HS CODE 9027 (TOP 20 COUNTRIES), 2020–2024 (USD THOUSAND) 97 TABLE 24 IMPORT VOLUME FOR HS CODE 9027 (TOP 20 COUNTRIES), 2020–2024 (TONS) 98 TABLE 25 EXPORT VALUE FOR HS CODE 9027 (TOP 20 COUNTRIES), 2020–2024 (USD THOUSAND) 99 TABLE 26 EXPORT VOLUME FOR HS CODE 9027 (TOP 20 COUNTRIES), 2020–2024 (TONS) 100 TABLE 27 US ADJUSTED RECIPROCAL TARIFF RATES 102 TABLE 28 CELL-BASED ASSAY PRODUCTS-RELATED TARIFF REVISION 103 TABLE 29 IMPACT ON END-USE APPLICATIONS OF CELL-BASED ASSAY PRODUCTS 105 TABLE 30 CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 108 TABLE 31 CONSUMABLES OFFERED BY KEY COMPANIES 109 TABLE 32 CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 110 TABLE 33 CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 34 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 35 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 36 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 37 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 38 MIDDLE EAST: CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 39 GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 40 REAGENTS OFFERED BY KEY COMPANIES 113 TABLE 41 REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 42 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 43 EUROPE: REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 44 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 45 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 46 MIDDLE EAST: REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 47 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 48 ASSAY KITS OFFERED BY KEY COMPANIES 117 TABLE 49 ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 117 TABLE 50 ASSAY KITS MARKET, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 51 NORTH AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 52 EUROPE: ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 53 ASIA PACIFIC: ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 54 LATIN AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 55 MIDDLE EAST: ASSAY KITS MARKET, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 56 GCC COUNTRIES: ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 57 REPORTER GENE ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 58 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 59 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 60 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 61 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 62 MIDDLE EAST: REPORTER GENE ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 63 GCC COUNTRIES: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 64 CELL GROWTH ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 65 NORTH AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 66 EUROPE: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 67 ASIA PACIFIC: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 68 LATIN AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 69 MIDDLE EAST: CELL GROWTH ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 70 GCC COUNTRIES: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 71 SECONDARY MESSENGER ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 72 NORTH AMERICA: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 73 EUROPE: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 74 ASIA PACIFIC: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 75 LATIN AMERICA: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 76 MIDDLE EAST: SECONDARY MESSENGER ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 77 GCC COUNTRIES: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 78 CELL DEATH ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 79 NORTH AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 80 EUROPE: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 81 ASIA PACIFIC: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 82 LATIN AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 83 MIDDLE EAST: CELL DEATH ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 84 GCC COUNTRIES: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 85 OTHER ASSAY KITS MARKET, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 86 NORTH AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 87 EUROPE: OTHER ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 88 ASIA PACIFIC: OTHER ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 89 LATIN AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 90 MIDDLE EAST: OTHER ASSAY KITS MARKET, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 91 GCC COUNTRIES: OTHER ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 92 MICROPLATES MARKET, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 93 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 94 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 95 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 96 LATIN AMERICA: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 97 MIDDLE EAST: MICROPLATES MARKET, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 98 GCC COUNTRIES: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 99 CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 141 TABLE 100 CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 101 NORTH AMERICA: CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 102 EUROPE: CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 103 ASIA PACIFIC: CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 104 LATIN AMERICA: CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 105 MIDDLE EAST: CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 106 GCC COUNTRIES: CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 107 IMMORTALIZED CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 108 NORTH AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 109 EUROPE: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 110 ASIA PACIFIC: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 111 LATIN AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 112 MIDDLE EAST: IMMORTALIZED CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 113 GCC COUNTRIES: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 114 PRIMARY CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 115 NORTH AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 116 EUROPE: PRIMARY CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 117 ASIA PACIFIC: PRIMARY CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 118 LATIN AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 119 MIDDLE EAST: PRIMARY CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 120 GCC COUNTRIES: PRIMARY CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 121 STEM CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 122 NORTH AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 123 EUROPE: STEM CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 124 ASIA PACIFIC: STEM CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 125 LATIN AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 126 MIDDLE EAST: STEM CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 127 GCC COUNTRIES: STEM CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 128 PROBES & LABELS MARKET, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 129 NORTH AMERICA: PROBES & LABELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 130 EUROPE: PROBES & LABELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 131 ASIA PACIFIC: PROBES & LABELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 132 LATIN AMERICA: PROBES & LABELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 133 MIDDLE EAST: PROBES & LABELS MARKET, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 134 GCC COUNTRIES: PROBES & LABELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 135 OTHER CONSUMABLES OFFERED BY KEY COMPANIES 158 TABLE 136 OTHER CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 137 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 138 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 139 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 140 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 141 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 142 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 143 INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 162 TABLE 144 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 145 EUROPE: INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 146 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 147 LATIN AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 148 MIDDLE EAST: INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 149 GCC COUNTRIES: INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 150 SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 165 TABLE 151 NORTH AMERICA: SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 152 EUROPE: SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 153 ASIA PACIFIC: SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 154 LATIN AMERICA: SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 155 MIDDLE EAST: SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 167 TABLE 156 GCC COUNTRIES: SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 157 SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 168 TABLE 158 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 159 EUROPE: SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 160 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 161 LATIN AMERICA: SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 162 MIDDLE EAST: SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 163 GCC COUNTRIES: SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 164 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 172 TABLE 165 CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2023–2030 (USD MILLION) 173 TABLE 166 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 167 EUROPE: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 168 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 169 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 170 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2023–2030 (USD MILLION) 175 TABLE 171 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 172 CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2023–2030 (USD MILLION) 176 TABLE 173 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 174 EUROPE: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 175 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 176 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 177 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2023–2030 (USD MILLION) 178 TABLE 178 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 179 CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY REGION, 2023–2030 (USD MILLION) 180 TABLE 180 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 181 EUROPE: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 182 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 183 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 184 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY REGION, 2023–2030 (USD MILLION) 182 TABLE 185 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 186 OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY REGION, 2023–2030 (USD MILLION) 183 TABLE 187 NORTH AMERICA: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 188 EUROPE: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 189 ASIA PACIFIC: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 190 LATIN AMERICA: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 191 MIDDLE EAST: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY REGION, 2023–2030 (USD MILLION) 185 TABLE 192 GCC COUNTRIES: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 193 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 187 TABLE 194 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 195 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 188 TABLE 196 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 197 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 198 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 199 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 200 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 191 TABLE 201 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 202 CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2023–2030 (USD MILLION) 192 TABLE 203 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 204 EUROPE: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 205 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 206 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 207 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2023–2030 (USD MILLION) 195 TABLE 208 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 209 CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2023–2030 (USD MILLION) 196 TABLE 210 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 211 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 212 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 213 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 214 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2023–2030 (USD MILLION) 198 TABLE 215 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 216 CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2023–2030 (USD MILLION) 200 TABLE 217 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 218 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 219 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 220 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 221 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2023–2030 (USD MILLION) 202 TABLE 222 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 223 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2023–2030 (USD MILLION) 204 TABLE 224 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 225 EUROPE: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 226 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 227 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 228 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2023–2030 (USD MILLION) 206 TABLE 229 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 230 CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY REGION, 2023–2030 (USD MILLION) 207 TABLE 231 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 232 EUROPE: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 233 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 234 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 235 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY REGION, 2023–2030 (USD MILLION) 209 TABLE 236 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 237 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 210 TABLE 238 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 239 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 240 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 241 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 242 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 213 TABLE 243 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 244 CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 215 TABLE 245 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION) 216 TABLE 246 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 217 TABLE 247 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 248 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 249 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 250 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 251 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 219 TABLE 252 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 253 CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2023–2030 (USD MILLION) 221 TABLE 254 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 255 EUROPE: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 256 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 257 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 258 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2023–2030 (USD MILLION) 223 TABLE 259 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 260 CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 224 TABLE 261 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 262 EUROPE: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 263 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 264 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 265 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 226 TABLE 266 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 267 CELL-BASED ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION) 229 TABLE 268 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 269 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 232 TABLE 270 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 271 NORTH AMERICA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 272 NORTH AMERICA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 273 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 233 TABLE 274 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 234 TABLE 275 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 276 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 234 TABLE 277 US: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 236 TABLE 278 US: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 279 US: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 280 US: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 281 US: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 237 TABLE 282 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 238 TABLE 283 US: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 284 US: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 238 TABLE 285 CANADA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 239 TABLE 286 CANADA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 287 CANADA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 288 CANADA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 289 CANADA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 241 TABLE 290 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 241 TABLE 291 CANADA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 292 CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 242 TABLE 293 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 243 TABLE 294 EUROPE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 243 TABLE 295 EUROPE: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 296 EUROPE: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 297 EUROPE: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 298 EUROPE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 245 TABLE 299 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 245 TABLE 300 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 301 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 246 TABLE 302 GERMANY: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 247 TABLE 303 GERMANY: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 304 GERMANY: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 305 GERMANY: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 306 GERMANY: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 248 TABLE 307 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 249 TABLE 308 GERMANY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 309 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 249 TABLE 310 UK: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 251 TABLE 311 UK: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 312 UK: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 313 UK: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 314 UK: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 252 TABLE 315 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 253 TABLE 316 UK: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 317 UK: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 253 TABLE 318 FRANCE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 255 TABLE 319 FRANCE: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 320 FRANCE: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 321 FRANCE: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 322 FRANCE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 256 TABLE 323 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 257 TABLE 324 FRANCE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 325 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 257 TABLE 326 ITALY: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 258 TABLE 327 ITALY: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 328 ITALY: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 329 ITALY: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 330 ITALY: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 259 TABLE 331 ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 260 TABLE 332 ITALY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 333 ITALY: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 260 TABLE 334 SPAIN: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 261 TABLE 335 SPAIN: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 336 SPAIN: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 337 SPAIN: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 338 SPAIN: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 263 TABLE 339 SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 263 TABLE 340 SPAIN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 341 SPAIN: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 264 TABLE 342 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 264 TABLE 343 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 344 REST OF EUROPE: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 345 REST OF EUROPE: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 346 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 266 TABLE 347 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 266 TABLE 348 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 349 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 267 TABLE 350 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 270 TABLE 351 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 270 TABLE 352 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 353 ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 354 ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 355 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 272 TABLE 356 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 272 TABLE 357 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 358 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 273 TABLE 359 CHINA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 274 TABLE 360 CHINA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 361 CHINA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 362 CHINA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 363 CHINA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 275 TABLE 364 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 276 TABLE 365 CHINA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 366 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 276 TABLE 367 JAPAN: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 277 TABLE 368 JAPAN: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 369 JAPAN: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 370 JAPAN: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 371 JAPAN: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 279 TABLE 372 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 279 TABLE 373 JAPAN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 374 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 280 TABLE 375 INDIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 281 TABLE 376 INDIA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 377 INDIA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 378 INDIA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 379 INDIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 282 TABLE 380 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 283 TABLE 381 INDIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 382 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 283 TABLE 383 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 284 TABLE 384 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 385 AUSTRALIA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 386 AUSTRALIA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 387 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 286 TABLE 388 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 286 TABLE 389 AUSTRALIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 390 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 287 TABLE 391 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 287 TABLE 392 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 393 SOUTH KOREA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 394 SOUTH KOREA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 395 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 289 TABLE 396 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 289 TABLE 397 SOUTH KOREA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 398 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 290 TABLE 399 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 291 TABLE 400 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 401 REST OF ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 402 REST OF ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 403 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 292 TABLE 404 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 293 TABLE 405 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 406 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 293 TABLE 407 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 295 TABLE 408 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 295 TABLE 409 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 410 LATIN AMERICA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 411 LATIN AMERICA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 412 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 297 TABLE 413 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 297 TABLE 414 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 415 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 298 TABLE 416 BRAZIL: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 299 TABLE 417 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 418 BRAZIL: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 419 BRAZIL: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 420 BRAZIL: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 300 TABLE 421 BRAZIL: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 301 TABLE 422 BRAZIL: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 423 BRAZIL: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 301 TABLE 424 MEXICO: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 302 TABLE 425 MEXICO: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 426 MEXICO: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 427 MEXICO: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 428 MEXICO: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 303 TABLE 429 MEXICO: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 304 TABLE 430 MEXICO: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 431 MEXICO: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 304 TABLE 432 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 305 TABLE 433 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 434 REST OF LATIN AMERICA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 435 REST OF LATIN AMERICA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 436 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 306 TABLE 437 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 307 TABLE 438 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 439 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 307 TABLE 440 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION) 308 TABLE 441 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 309 TABLE 442 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 443 MIDDLE EAST: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 444 MIDDLE EAST: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 445 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 310 TABLE 446 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 311 TABLE 447 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 448 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 311 TABLE 449 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 312 TABLE 450 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 312 TABLE 451 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 452 GCC COUNTRIES: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 453 GCC COUNTRIES: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 454 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 314 TABLE 455 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 314 TABLE 456 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 457 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 315 TABLE 458 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 316 TABLE 459 SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 460 SAUDI ARABIA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 461 SAUDI ARABIA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 462 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 317 TABLE 463 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 318 TABLE 464 SAUDI ARABIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 465 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 318 TABLE 466 UAE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 319 TABLE 467 UAE: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 468 UAE: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 469 UAE: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 470 UAE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 320 TABLE 471 UAE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 321 TABLE 472 UAE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 473 UAE: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 321 TABLE 474 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 322 TABLE 475 REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 476 REST OF GCC COUNTRIES: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 477 REST OF GCC COUNTRIES: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 478 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 324 TABLE 479 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 324 TABLE 480 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 481 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 325 TABLE 482 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 326 TABLE 483 REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 484 REST OF MIDDLE EAST: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 485 REST OF MIDDLE EAST: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 486 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 327 TABLE 487 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 328 TABLE 488 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 489 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 328 TABLE 490 AFRICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 330 TABLE 491 AFRICA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 492 AFRICA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 493 AFRICA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 494 AFRICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 331 TABLE 495 AFRICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 332 TABLE 496 AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 497 AFRICA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION) 332 TABLE 498 OVERVIEW OF STRATEGIES DEPLOYED BY MANUFACTURING COMPANIES, JANUARY 2021–APRIL 2025 334 TABLE 499 CELL-BASED ASSAYS MARKET: DEGREE OF COMPETITION 338 TABLE 500 CELL-BASED ASSAYS MARKET: OFFERING FOOTPRINT 343 TABLE 501 CELL-BASED ASSAYS MARKET: TECHNOLOGY FOOTPRINT 344 TABLE 502 CELL-BASED ASSAYS MARKET: APPLICATION FOOTPRINT 345 TABLE 503 CELL-BASED ASSAYS MARKET: REGION FOOTPRINT 346 TABLE 504 CELL-BASED ASSAYS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 349 TABLE 505 CELL-BASED ASSAYS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 351 TABLE 506 CELL-BASED ASSAYS MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 354 TABLE 507 CELL-BASED ASSAYS MARKET: DEALS, JANUARY 2021–APRIL 2025 355 TABLE 508 CELL-BASED ASSAYS MARKET: EXPANSIONS, JANUARY 2021–APRIL 2025 356 TABLE 509 DANAHER: COMPANY OVERVIEW 357 TABLE 510 DANAHER: PRODUCTS/SERVICES OFFERED 359 TABLE 511 DANAHER: DEALS, JANUARY 2021–APRIL 2025 361 TABLE 512 DANAHER: EXPANSIONS, JANUARY 2021–APRIL 2025 362 TABLE 513 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 363 TABLE 514 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 364 TABLE 515 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–APRIL 2025 368 TABLE 516 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–APRIL 2025 369 TABLE 517 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 369 TABLE 518 MERCK KGAA: COMPANY OVERVIEW 371 TABLE 519 MERCK KGAA: PRODUCTS/SERVICES OFFERED 372 TABLE 520 MERCK KGAA: DEALS, JANUARY 2021–APRIL 2025 375 TABLE 521 MERCK KGAA: EXPANSIONS, JANUARY 2021–APRIL 2025 375 TABLE 522 BD: BUSINESS OVERVIEW 377 TABLE 523 BD: PRODUCTS/SERVICES OFFERED 378 TABLE 524 BD: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 381 TABLE 525 BD: DEALS, JANUARY 2021–APRIL 2025 381 TABLE 526 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 383 TABLE 527 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 384 TABLE 528 AGILENT TECHNOLOGIES, INC.: PRODUCTS LAUNCHES, JANUARY 2021–APRIL 2025 385 TABLE 529 LONZA: COMPANY OVERVIEW 387 TABLE 530 LONZA: PRODUCTS/SERVICES OFFERED 388 TABLE 531 LONZA: DEALS, JANUARY 2021–APRIL 2025 389 TABLE 532 LONZA: EXPANSIONS, JANUARY 2021–APRIL 2025 389 TABLE 533 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 390 TABLE 534 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 391 TABLE 535 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–APRIL 2025 393 TABLE 536 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 394 TABLE 537 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED 395 TABLE 538 CHARLES RIVER LABORATORIES: SERVICE LAUNCHES, JANUARY 2021–APRIL 2025 397 TABLE 539 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–APRIL 2025 397 TABLE 540 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 399 TABLE 541 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 400 TABLE 542 REVVITY: COMPANY OVERVIEW 402 TABLE 543 REVVITY: PRODUCTS/SERVICES OFFERED 403 TABLE 544 REVVITY: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 405 TABLE 545 SARTORIUS AG: COMPANY OVERVIEW 406 TABLE 546 SARTORIUS AG: PRODUCTS/SERVICES OFFERED 408 TABLE 547 SARTORIUS AG: EXPANSIONS, JANUARY 2021–APRIL 2025 408 TABLE 548 CORNING INCORPORATED: COMPANY OVERVIEW 409 TABLE 549 CORNING INCORPORATED: PRODUCTS/SERVICES OFFERED 410 TABLE 550 PROMEGA CORPORATION: COMPANY OVERVIEW 412 TABLE 551 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED 412 TABLE 552 PROMEGA CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 413 TABLE 553 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW 414 TABLE 554 CELL SIGNALING TECHNOLOGY, INC.: PRODUCTS/SERVICES OFFERED 414 TABLE 555 ENZO BIOCHEM INC.: COMPANY OVERVIEW 416 TABLE 556 ENZO BIOCHEM INC.: PRODUCTS/SERVICES OFFERED 417 TABLE 557 ENZO BIOCHEM INC.: EXPANSIONS, JANUARY 2021–APRIL 2025 419 TABLE 558 CARNA BIOSCIENCES, INC.: BUSINESS OVERVIEW 420 TABLE 559 CARNA BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED 421 TABLE 560 INTERTEK GROUP PLC: COMPANY OVERVIEW 423 TABLE 561 INTERTEK GROUP PLC: PRODUCTS /SERVICES OFFERED 424 TABLE 562 INTERTEK GROUP PLC: EXPANSIONS, JANUARY 2021–APRIL 2025 425 TABLE 563 BICO: COMPANY OVERVIEW 426 TABLE 564 BICO: PRODUCTS/SERVICES OFFERED 427 FIGURE 1 CELL-BASED ASSAYS MARKET: SEGMENTS & REGIONS CONSIDERED 40 FIGURE 2 RESEARCH DESIGN 43 FIGURE 3 BREAKDOWN OF PRIMARIES: CELL-BASED ASSAYS MARKET 45 FIGURE 4 CELL-BASED ASSAYS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 46 FIGURE 5 MARKET SIZE ESTIMATION: GLOBAL MARKET ESTIMATION (BOTTOM-UP APPROACH), 2024 47 FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS (2024) 47 FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 48 FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 49 FIGURE 9 CELL-BASED ASSAYS MARKET: CAGR PROJECTIONS 50 FIGURE 10 DATA TRIANGULATION METHODOLOGY 52 FIGURE 11 CELL-BASED ASSAYS MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 55 FIGURE 12 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 56 FIGURE 13 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 56 FIGURE 14 CELL-BASED ASSAYS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 57 FIGURE 15 GEOGRAPHICAL SNAPSHOT OF CELL-BASED ASSAYS MARKET 58 FIGURE 16 GROWING DEMAND FOR DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET 59 FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2024 60 FIGURE 18 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 60 FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT HELD MAJOR MARKET SHARE IN 2024 61 FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 61 FIGURE 21 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62 FIGURE 22 AGE-STANDARDIZED RATE (WORLD) PER 100,000 CANCER INCIDENCES IN BOTH SEXES, 2022 67 FIGURE 23 CELL-BASED ASSAYS MARKET: VALUE CHAIN ANALYSIS 77 FIGURE 24 PRICING ANALYSIS FOR CELL-BASED ASSAY PRODUCTS, 2022–2024 78 FIGURE 25 CELL-BASED ASSAYS MARKET ECOSYSTEM 80 FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 83 FIGURE 27 PATENT APPLICATION IN CELL-BASED ASSAYS MARKET, JANUARY 2014–APRIL 2025 84 FIGURE 28 CELL-BASED ASSAYS MARKET: PORTER’S FIVE ANALYSIS 92 FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL-BASED ASSAY PRODUCTS 94 FIGURE 30 KEY BUYING CRITERIA FOR END USERS 95 FIGURE 31 CELL-BASED ASSAYS MARKET: INVESTMENT AND FUNDING SCENARIO, 2020-2024 96 FIGURE 32 IMPACT OF AI/GEN AI ON CELL-BASED ASSAYS MARKET 101 FIGURE 33 INSTRUMENTS MARKET (FLOW CYTOMETERS) FOR CELL-BASED ASSAYS, 2023–2030 (THOUSAND UNITS) 162 FIGURE 34 WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2021–2028 216 FIGURE 35 NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT 231 FIGURE 36 ASIA PACIFIC: CELL-BASED ASSAYS MARKET SNAPSHOT 269 FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN CELL-BASED ASSAYS MARKET (2020–2024) 337 FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL-BASED ASSAYS MARKET (2024) 338 FIGURE 39 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 341 FIGURE 40 CELL-BASED ASSAYS MARKET: COMPANY FOOTPRINT 342 FIGURE 41 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2024 348 FIGURE 42 EV/EBITDA OF KEY VENDORS 352 FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 352 FIGURE 44 CELL-BASED ASSAYS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 353 FIGURE 45 DANAHER: COMPANY SNAPSHOT (2024) 358 FIGURE 46 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 364 FIGURE 47 MERCK KGAA: COMPANY SNAPSHOT (2024) 372 FIGURE 48 BD: COMPANY SNAPSHOT (2024) 378 FIGURE 49 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 384 FIGURE 50 LONZA: COMPANY SNAPSHOT (2024) 388 FIGURE 51 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024) 391 FIGURE 52 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024) 395 FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 400 FIGURE 54 REVVITY: COMPANY SNAPSHOT (2024) 403 FIGURE 55 SARTORIUS AG: COMPANY SNAPSHOT (2024) 407 FIGURE 56 CORNING INCORPORATED: COMPANY SNAPSHOT (2024) 410 FIGURE 57 ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2024) 416 FIGURE 58 CARNA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2024) 421 FIGURE 59 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2024) 424 FIGURE 60 BICO: COMPANY SNAPSHOT (2024) 427

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Cell Based Assays Market by Offering (Consumables (Reagents, Assay Kits, Cell Lines, Microplates, Probes, Labels), Instruments & Software), Technology (Flow Cytometry, HTS), Application (Drug Discovery (Toxicity, PK/PD Studies)) - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（醫療與生命科學）